Skip to content

About Us

Our Team

Nathan Teuscher

Nathan Teuscher
President and Founder

Nathan is a global expert in pharmacokinetics, clinical pharmacology, and drug development.

erik

Eric Wilson
CTO and Technical Founder

Eric is a seasoned AWS specialist and event-driven architecture enthusiast, passionately reducing complexity and streamlining operations through automation.

Frequently Asked Questions

What does Aplos mean?

Aplos in Greek (απλώς) means "simply". We chose this name because data analysis should be simple to understand and simple to perform with the right tool. Aplos Analytics strives to create software tools to simplify the work of data analysts so that they can spend more time doing the valuable work of interpreting results.

How do you keep my data confidential?

The confidentiality and security of your data is a fundamental concern for Aplos Analytics. All information transfers are performed using encrypted communication between your computer and the Aplos Analytics servers. This is the same encryption used for secure financial transactions on the internet. Data is stored securely in our private cloud storage instance. 

What do I have to install to use Aplos NCA?

Nothing! Aplos NCA is a cloud-based API (application programming interface) that does not require any local software. You can access Aplos NCA through the web interface that we provide or using locally installed software such as R, python, and SAS. You can even write your own proprietary software to interact with Aplos NCA API. The calculation engine and file storage reside on private, secure cloud servers. That means that you can access the software from any computer, tablet, or phone that has an active internet connection.

Does the FDA accept results from Aplos NCA?

Yes! The FDA does not recommend or require the use of particular software for conducting pharmacokinetic analysis. The sponsor is required to report the software used and submit the electronic files supporting the analysis and results. All of the input and output files from Aplos NCA are human-readable and in a format acceptable for submission to the FDA. Unlike other products, no proprietary data formats are used by Aplos NCA.